Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


Cell Based Assays

18 Nov 2013 - 19 Nov 2013 - London, UK



Bookmark and Share


SMi is proud to present their 6th Annual...

Cell Based Assays

Following on from our hugely successful Cell-Based Assays conference in 2012, this year's agenda will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet.

Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years.

There are currently 15 FDA approved kinase inhibitor drugs, but there currently remains a huge uncapped potential with these drugs as over 90% of the kinome is unknown. Novel assays have identified kinase targets, improved the function of kinase inhibitors and led to an acceleration in drug discovery with new inhibitor classes.

See at Cell Based Assays 2013 how HCA can be utilised in your pre-clinical toxicology procedures to give highly accurate data.

WHY ATTEND THIS EVENT: 

Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules

See how you can implement a primary cell assay plan through a case study of SARdriving assay

The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays

Adopt accelerated primary cell screening systems such as those utilised by GSK

KEYNOTE SPEAKERS INCLUDE:

Mao Xiang Chen, Biological and Cellular targets, GlaxoSmithKline

Martha Brown, Senior Associate Director, Boehringer-Ingelheim

Xavier Leroy, Director, Actelion

Steve Ludbrook, Section Head, GlaxoSmithKline

Urs Luethi, Senior Lab Head Discovery, Actelion

Anthony Davies, Director, Trinity College Dublin

Tyrell Norris, Team Leader – Cellular Reagents & Assay Development, AstraZeneca

Amir Gander, Senior Knowledge Transfer Associate, University College London

**Book by 19th July 2013 and save £300**

**Book by 31st September 2013 and save £100**

Visit our website here:  http://ww.smi-online.co.uk/goto/2013cellbasedassay20.asp

Alternatively, contact Fateja Begum on +44 (0)20 7827 6184 or email:  fbegum@smi-online.co.uk



Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!